RedHill Biopharma Balance Sheet Health
Financial Health criteria checks 3/6
RedHill Biopharma has a total shareholder equity of $61.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $22.0M and $22.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.28m |
| Equity | US$61.00k |
| Total liabilities | US$21.96m |
| Total assets | US$22.02m |
Recent financial health updates
Recent updates
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate
Sep 10
RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks
Jul 28One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts
Nov 24RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency
Oct 18RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease
Aug 17RedHill: Given Up For Dead
Apr 30RedHill Biopharma: Looking At An Unexciting Dead-End
Dec 30RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target
Dec 02Financial Position Analysis
Short Term Liabilities: RDHL's short term assets ($15.7M) do not cover its short term liabilities ($21.2M).
Long Term Liabilities: RDHL's short term assets ($15.7M) exceed its long term liabilities ($730.0K).
Debt to Equity History and Analysis
Debt Level: RDHL is debt free.
Reducing Debt: RDHL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RDHL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RDHL has less than a year of cash runway if free cash flow continues to grow at historical rates of 5.9% each year.